Apricus Biosciences Inc. (NASDAQ:APRI): Alex Denner’s Sarissa Capital Management filed an amended 13D.
You can check out Sarissa Capital Management’s latest holdings and filings here.
Please follow Sarissa Capital Management (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Sarissa Capital Management or update its stock holdings.
Follow Alex Denner's Sarissa Capital Management
You can access the original SEC filing by clicking here.
Page 1 of 3 – SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Apricus Biosciences, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
Sarissa Capital Management LP
660 Steamboat Road
Greenwich, CT 06830
With a copy to:
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, New York 10019
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
March 21, 2018
(Date of Event which Requires Filing of this Statement)